URSA-PHARM-R08: Patients with Active PDC Medication
- 27 Apr 2023
- 1 Minute to read
- Print
- DarkLight
URSA-PHARM-R08: Patients with Active PDC Medication
- Updated on 27 Apr 2023
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback
Measure Description
Includes patient periods of active plan membership during which the patient has one or more active medication therapy episode for any of the three medication classes included in the PDC measures; (1) Oral Antidiabetics, (2) Oral ACEI/ARBs, or (3) Statins
Metadata
- Measure Type: Registry
- Temporal Structure: Entity
- Component Class: Normal-Form
- Denominator Case Field: Patient ID
- Target Direction: None
Related Key Concepts
None.
FAQs
None.
Was this article helpful?